Catalent Inc (CTLT) Stock Price Today
Key Stats
- $11.52BMarket Cap
- -Volume
- HealthSector
- $63.4852W High
- $58.4852W Low
- -Typical Hold Time
- $16.13BEnterprise Value
- -Div Yield
- -Trading Activity
Track Catalent Inc (CTLT) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Catalent Inc has traded between a low of $58.48 and a high of $63.48, highlighting its annual price range. Buy and sell Catalent Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Catalent Inc
Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.
Most Recent News
Evotec and Odyssey team up to fast-track new autoimmune and inflammatory disease treatments using AI and advanced screening.
Evotec SE has entered a strategic R&D collaboration with Odyssey Therapeutics to discover new treatments for autoimmune and inflammatory diseases. The partnership leverages Evotec's AI-driven discovery platform, advanced screening, and proprietary co...
Google's AI talent exits amid cloud growth and strategic shifts in AI focus
Google is facing a challenge balancing its booming cloud business, which grew 82% in Q2, with its commitment to frontier AI research. Key AI leaders like Jeff Dean and Demis Hassabis are stepping down or shifting roles, raising concerns about Google'...
ARCpoint faces trading halt after failing to file 2026 audited financials by deadline.
ARCpoint Inc. has been issued a failure-to-file cease trade order by the British Columbia Securities Commission due to missing its July 29, 2026 deadline to file audited annual financial statements and related documents for the year ended March 31, 2...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.